DOI QR코드

DOI QR Code

Multicenter Evaluation of Seegene Anyplex TB PCR for the Detection of Mycobacterium tuberculosis in Respiratory Specimens

  • Lim, Jinsook (Department of Laboratory Medicine, Chungnam National University Hospital) ;
  • Kim, Jimyung (Department of Laboratory Medicine, Chungnam National University Hospital) ;
  • Kim, Jong Wan (Department of Laboratory Medicine, Dankook University) ;
  • Ihm, Chunhwa (Department of Laboratory Medicine, Eul-ji University Hospital) ;
  • Sohn, Yong-Hak (Department of Laboratory Medicine, Eul-ji University Hospital) ;
  • Cho, Hyun-Jung (Department of Laboratory Medicine, Konyang University Hospital) ;
  • Kim, Jayoung (Department of Laboratory Medicine, International St. Mary's Hospital, Incheon Catholic Medical Center) ;
  • Koo, Sun Hoe (Department of Laboratory Medicine, Chungnam National University Hospital)
  • 투고 : 2014.04.01
  • 심사 : 2014.04.29
  • 발행 : 2014.07.28

초록

Culture is the gold standard for diagnosis of tuberculosis, but it takes 6 to 8 weeks to confirm the result. This issue is complemented by the detection method using polymerase chain reaction, which is now widely used in a routine microbiology laboratory. In this study, we evaluated the performance of the Seegene Anyplex TB PCR to assess its diagnostic sensitivity and specificity, and compared its results with the Roche Cobas TaqMan MTB PCR, one of the most widely used assays in the world. Five university hospitals located in the Chungcheong area in South Korea participated in the study. A total of 1,167 respiratory specimens ordered for acid-fast bacilli staining and culture were collected for four months, analyzed via the Seegene Anyplex TB PCR, and its results were compared with the Roche Cobas TaqMan MTB PCR. For detection of Mycobacterium tuberculosis, the diagnostic sensitivity and specificity of the Anyplex TB PCR were 87.5% and 98.2% respectively, whereas those of the Cobas TaqMan were 92.0% and 98.0% respectively (p value > 0.05). For smear-positive specimens, the sensitivity of the Anyplex TB PCR was 95.2%, which was exactly the same as that of the Cobas TaqMan. For smear-negative specimens, the sensitivity of the Anyplex TB PCR was 69.2%, whereas that of the Cobas TaqMan TB PCR was 84.6%. For detection of MTB, the Seegene Anyplex TB PCR showed excellent diagnostic performance, and high sensitivity and specificity, which were comparable to the Roche Cobas TaqMan MTB PCR. In conclusion, the Anyplex TB PCR can be a useful diagnostic tool for the early detection of tuberculosis in clinical laboratories.

키워드

참고문헌

  1. Antonenka U, Hofmann-Thiel S, Taraev L, Esenalieva A, Abdulloeva M, Sahalchyk E, et al. 2013. Comparison of Xpert MTB/RIF with ProbeTec ET DTB and Cobas Taqman MTB for direct detection of tuberculosis complex in respiratory specimens. BMC Infect. Dis. 13: 280. https://doi.org/10.1186/1471-2334-13-280
  2. Behr MA, Warren SA, Salamon H, Hopewell PC, Ponce de Leon A, Daley CL, et al. 1999. Transmission of Mycobacterium tuberculosis from patients smear negative for acid-fast bacilli. Lancet 353: 444-449. https://doi.org/10.1016/S0140-6736(98)03406-0
  3. Center for Disease Control. 2012. Report of an expert consultation on the use of nucleic acid amplification tests for the diagnosis of tuberculosis. Available at http://www.cdc.gov/ tb/publications/guidelines/amplification_tests/amplification_tests. pdf. (Updated on September 2012.)
  4. Chang CL, Park TS, Kim MN, Lee NY, Lee HJ, Suh JT. 2001. Survey on changes in mycobacterial testing practices in Korean Laboratories. Korean J. Clin. Microbiol. 4: 108-114.
  5. Kim JH, Kim YJ, Ki CS, Kim JY, Lee NY. 2011. Evaluation of Cobas Taqman MTB PCR for detection of Mycobacterium tuberculosis. J. Clin. Microbiol. 49: 173-176. https://doi.org/10.1128/JCM.00694-10
  6. Lawn SD, Mwaba P, Bates M, Piatek A, Alenxander H, Marais BJ, et al. 2013. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a pointof- care test. Lancet. Infect. Dis. 13: 349-361. https://doi.org/10.1016/S1473-3099(13)70008-2
  7. Sarmiento OL, Weigle KA, Alexander J, Weber DJ, Ammerman AS. 2003. Assessment by meta-analysis of PCR for diagnosis of smear-negative pulmonary tuberculosis. J. Clin. Microbiol. 41: 3233-3240. https://doi.org/10.1128/JCM.41.7.3233-3240.2003
  8. Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, et al. 2014. Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst. Rev. 21: 1.
  9. Stewart SM. 1953. The bacteriological diagnosis of tuberculosis meningitis. J. Clin. Pathol. 6: 241-242. https://doi.org/10.1136/jcp.6.3.241
  10. Tortoli E, Russo C, Pieersimoni C, Mazzola E, Dal Monte P, Pascarella M, et al. 2012. Clinical validation of Xpert MTB/ RIF for the diagnosis of extrapulmonary tuberculosis. Eur. Respir. J. 40: 442-447. https://doi.org/10.1183/09031936.00176311
  11. Tortoli E, Urbano P, Marcelli F, Simonetti TM, Cirillo DM. 2012. Is real-time PCR better than conventional PCR for Mycobacterium tuberculosis complex detection in clinical samples? J. Clin. Microbiol. 50: 2810-2813. https://doi.org/10.1128/JCM.01412-12
  12. World Health Organization. 2013. Global tuberculosis report 2013. Publication No. WHO/HTM/TB/2013.11.
  13. Yang YC, Lu PL, Huang SC, Jenh YS, Jou R, Chang TC. 2011. Evaluation of the Cobas Taqman MTB test for direct detection of Mycobacterium tuberculosis complex in respiratory specimen. J. Clin. Microbiol. 49: 797-801. https://doi.org/10.1128/JCM.01839-10

피인용 문헌

  1. Performance Evaluation of Anyplex Plus MTB/NTM and MDR-TB Detection Kit for Detection of Mycobacteria and for Anti-Tuberculosis Drug Susceptibility Test vol.17, pp.4, 2014, https://doi.org/10.5145/acm.2014.17.4.115
  2. Performance Evaluation of Anyplex plus MTB/NTM and AdvanSure TB/NTM for the Detection ofMycobacterium tuberculosisand Nontuberculous Mycobacteria vol.18, pp.2, 2014, https://doi.org/10.5145/acm.2015.18.2.44
  3. Simple Detection of the IS 6110 Sequence of Mycobacterium tuberculosis Complex in Sputum, Based on PCR with Graphene Oxide vol.10, pp.8, 2014, https://doi.org/10.1371/journal.pone.0136954
  4. Performance of the new automated Abbott RealTime MTB assay for rapid detection of Mycobacterium tuberculosis complex in respiratory specimens vol.34, pp.9, 2014, https://doi.org/10.1007/s10096-015-2419-5
  5. Comparative Study of a Real-Time PCR Assay Targeting senX3-regX3 versus Other Molecular Strategies Commonly Used in the Diagnosis of Tuberculosis vol.10, pp.11, 2014, https://doi.org/10.1371/journal.pone.0143025
  6. Evaluation of the Abbott RealTime MTB and RealTime MTB INH/RIF Assays for Direct Detection of Mycobacterium tuberculosis Complex and Resistance Markers in Respiratory and Extrapulmonary Specimens vol.54, pp.12, 2014, https://doi.org/10.1128/jcm.01144-16
  7. Improved performance of the artus Mycobacterium tuberculosis RG PCR kit in a low incidence setting: a retrospective monocentric study vol.7, pp.None, 2017, https://doi.org/10.1038/s41598-017-14367-z
  8. Effectiveness of real-time polymerase chain reaction assay for the detection of Mycobacterium tuberculosis in pathological samples: a systematic review and meta-analysis vol.6, pp.1, 2014, https://doi.org/10.1186/s13643-017-0608-2
  9. A case of pulmonary infection caused by Mycobacterium asiaticum: Difficulties on diagnostic and therapeutic approaches vol.24, pp.None, 2014, https://doi.org/10.1016/j.rmcr.2018.05.014
  10. Distribution of Mycobacterium tuberculosis in Korea in the preceding decade vol.32, pp.4, 2014, https://doi.org/10.1002/jcla.22325
  11. Evaluation of EZplex MTBC/NTM Real-Time PCR kit: diagnostic accuracy and efficacy in vaccination vol.7, pp.2, 2018, https://doi.org/10.7774/cevr.2018.7.2.111
  12. Comparison of the Genedia MTB/NTM Detection Kit and Anyplex plus MTB/NTM Detection Kit for detection of Mycobacterium tuberculosis complex and nontuberculous mycobacteria in clinical specimens vol.34, pp.1, 2014, https://doi.org/10.1002/jcla.23021
  13. Evaluation of a semi‐automated Seegene PCR workflow with MTB, MDR, and NTM detection for rapid screening of tuberculosis in a low‐prevalence setting vol.128, pp.5, 2014, https://doi.org/10.1111/apm.13040